Clinical Trial: A single-arm, national, multi-center, exploratory clinical study of Retlirafusp alfa combined with famitinib and hepatic arterial infusion chemotherapy (HAIC-GEMOX) in the perioperative treatment of locally advanced intrahepatic cholangiocarcinoma (ICC) (China)

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-arm, national, multi-center, exploratory clinical study of Retlirafusp alfa combined with famitinib and hepatic arterial infusion chemotherapy (HAIC-GEMOX) in the perioperative treatment of locally advanced intrahepatic cholangiocarcinoma (ICC)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130568

Registration Time: 2026/08/21

Type: Interventional study

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339311

Published by HT Digital Conte...